www.novartis.com Open in urlscan Pro
172.64.154.11  Public Scan

Submitted URL: http://novartis.com/
Effective URL: https://www.novartis.com/
Submission: On May 13 via manual from US — Scanned from DE

Form analysis 2 forms found in the DOM

GET /search

<form action="/search" method="get" id="views-exposed-form-global-search-global-search" accept-charset="UTF-8" class="views-exposed-form-global-search-global-search" data-once="bef-auto-submit">
  <div class="wrap-global-search-result container">
    <div class="js-form-item js-form-type-search-api-autocomplete form-type-search-api-autocomplete js-form-item-keyword form-item-keyword form-no-label mb-3">
      <label for="edit-keyword" class="visually-hidden">Search</label>
      <div>
        <input placeholder="Search" data-drupal-selector="edit-keyword" data-search-api-autocomplete-search="global_search" class="form-autocomplete form-text form-control arc-input ui-autocomplete-input"
          data-autocomplete-path="/search_api_autocomplete/global_search?display=global_search&amp;&amp;filter=keyword" type="text" id="edit-keyword" name="keyword" value="" size="30" maxlength="128" data-once="autocomplete search-api-autocomplete"
          autocomplete="off">
      </div>
    </div>
    <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper mb-3" id="edit-actions">
      <div>
        <input data-bef-auto-submit-click="" data-drupal-selector="edit-submit-global-search" type="submit" id="edit-submit-global-search" value="Search" class="button js-form-submit form-submit btn btn-primary form-control arc-input">
      </div>
    </div>
  </div>
  <div class="search-clear-all" style="display: none;">
    <div>
      <input onclick="clearAllFilterButton(); return false;" data-drupal-selector="edit-button" type="submit" id="edit-button" name="op" value="Clear All" class="button js-form-submit form-submit form-control arc-input">
    </div>
  </div>
</form>

GET /search

<form action="/search" method="get" id="search-block-form" accept-charset="UTF-8" class="search-form search-block-form form-row">
  <div class="js-form-item js-form-type-textfield form-type-textfield js-form-item-keyword form-item-keyword form-no-label mb-3">
    <label class="searchForm visually-hidden" for="edit-keys">Search</label>
    <div>
      <input placeholder="Search" id="edit-keys" data-drupal-selector="edit-keyword" type="text" name="keyword" value="" size="60" maxlength="128" class="form-text form-control arc-input">
    </div>
  </div>
  <div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper mb-3" id="edit-actions--2">
    <div>
      <input data-drupal-selector="edit-submit" type="submit" id="edit-submit" value="Search" class="button js-form-submit form-submit btn btn-primary form-control arc-input">
    </div>
  </div>
</form>

Text Content

Skip to main content
 * Search
   Search
   
   
   

Global | en
Choose Location
 * International
 * Americas
 * Asia Pacific
 * Europe
 * Middle East & Africa

Global | English Novartis Foundation | English(link is external)
Argentina | Español Brazil | Português Canada | English Canada | Français
Central America | Español Colombia | Español Mexico | Español United States |
English
Australia | English Bangladesh | English Hong Kong S.A.R. | 繁體中文 India | English
Indonesia | English Japan | 日本語 Korea | 한국어 Mainland China | 中文 Malaysia |
English Pakistan | English Philippines | English Singapore | English Taiwan |
繁體中文 Thailand | ภาษาไทย
Austria | Deutsch Belgium | Français Belgium | Nederlands Bulgaria | Български
Czech Republic | Česky Czech Republic | English Denmark | Dansk Estonia | Eesti
Finland | Suomalainen France | Français Germany | Deutsch Greece | Ελληνικά
Hungary | Magyar Ireland | English Italy | Italiano Latvia | Latvian Lithuania |
Lithuanian Netherlands | Nederlands Norway | Norsk Poland | Polski Portugal |
Português Romania | Română Russia | Русский Serbia | Srpski Slovakia | Slovensky
Slovenia | Slovenščina Slovenia | English Spain | Español Sweden | Svenska
Switzerland | Deutsch Switzerland | Français Türkiye | Türkçe United Kingdom |
English
Egypt | English Israel | עברית Saudi Arabia | العربية South Africa | English
Global
Choose Location
international
International Americas Asia Pacific Europe Middle East & Africa
Argentina | Español Australia | English Austria | Deutsch Bangladesh | English
Belgium | Français Belgium | Nederlands Brazil | Português Bulgaria | Български
Canada | English Canada | Français Central America | Español Colombia | Español
Czech Republic | Česky Czech Republic | English Denmark | Dansk Egypt | English
Estonia | Eesti Finland | Suomalainen France | Français Germany | Deutsch Greece
| Ελληνικά Hong Kong S.A.R. | 繁體中文 Hungary | Magyar India | English Indonesia |
English Ireland | English Israel | עברית Italy | Italiano Japan | 日本語 Korea |
한국어 Latvia | Latvian Lithuania | Lithuanian Mainland China | 中文 Malaysia |
English Mexico | Español Netherlands | Nederlands Norway | Norsk Global |
English Novartis Foundation | English(link is external) Pakistan | English
Philippines | English Poland | Polski Portugal | Português Romania | Română
Russia | Русский Saudi Arabia | العربية Serbia | Srpski Singapore | English
Slovakia | Slovensky Slovenia | Slovenščina Slovenia | English South Africa |
English Spain | Español Sweden | Svenska Switzerland | Deutsch Switzerland |
Français Taiwan | 繁體中文 Thailand | ภาษาไทย Türkiye | Türkçe United Kingdom |
English United States | English
 * Menu
    * About 
      
      
      
      
      
       * Board of Directors 
         
         
         
         
         
          * Joerg Reinhardt 
          * Simon Moroney 
          * Nancy C. Andrews 
          * Ton Buechner 
          * Patrice Bula 
          * Elizabeth (Liz) Doherty 
          * Ana de Pro Gonzalo 
          * Bridgette Heller 
          * Daniel Hochstrasser 
          * Frans van Houten 
          * Charles L. Sawyers 
          * William T. Winters 
          * John D. Young 
          * Charlotte Pamer-Wieser 
         
         
       * Executive Committee 
         
         
         
         
         
          * Vasant (Vas) Narasimhan 
          * Shreeram Aradhye 
          * Victor Bulto 
          * Aharon (Ronny) Gal 
          * Karen L. Hale 
          * Patrick Horber 
          * Harry Kirsch 
          * Rob Kowalski 
          * Steffen Lang 
          * Fiona Marshall 
          * Klaus Moosmayer 
          * Lutz Hegemann 
          * Kees Roks 
          * Michelle Weese 
      
       * Products 
       * Therapeutic areas 
         
         
         
         
         
          * Cardiovascular, renal and metabolic 
          * Immunology 
          * Neuroscience 
          * Oncology 
      
       * People and culture 
       * Diversity, equity and inclusion 
         
         
         
         
         
          * Equity 
          * Inclusivity 
          * Parental leave 
          * Society 
      
       * Novartis Gene Therapies 
       * Manufacturing 
       * Quality 
         
         
         
         
         
          * Audit program 
          * Novartis quality management system (QMS) 
          * Product and patient safety training 
          * Regulatory inspections 
          * Product recalls 
          * Third-party suppliers 
      
       * Awards and recognition 
      
      About
      
      Novartis is an innovative medicines company. Every day, we work to
      reimagine medicine to improve and extend people’s lives so that patients,
      healthcare professionals and societies are empowered in the face of
      serious disease. Our medicines reach more than 250 million people
      worldwide.
   
    * Patients and caregivers 
      
      
      
      
      
       * Novartis commitment to patients and caregivers 
       * Diseases 
       * Patient organization funding 
       * Patients perspectives stories 
      
      Patients and caregivers
      
      Information for patients and their caregivers including clinical trial
      recruiting, managed access programs, funding opportunities for patient
      organizations and side effects reporting.
   
    * Healthcare professionals 
      
      
      
      
      
       * Medical congresses and events 
         
         
         
         
         
          * Abstract summaries for EULAR 
          * Abstract summaries for ACR 
          * ASCO annual meeting 
         
         
       * Products 
       * Novartis pipeline 
       * Managed access programs 
         
         
         
         
         
          * Novartis Gene Therapies managed access program 
      
       * Novartis external funding 
       * Healthcare professional resources by country 
       * Investigator-initiated trials / studies 
       * Novartis medical information 
         
         
         
         
         
          * Submit medical enquiry 
      
      Healthcare professionals
      
      Resources for physicians and other healthcare professionals including
      clinical trial recruiting, grant funding, congresses and country-level
      information.
   
    * Research and development 
      
      
      
      
      
       * Technology platforms 
       * Research disease areas 
         
         
         
         
         
          * Cardiovascular and metabolic disease research at Novartis 
          * DAx: exploratory disease research at Novartis 
          * Global Health disease area research at Novartis 
          * Immunology disease research at Novartis 
          * Neuroscience research at Novartis 
          * Oncology research at Novartis 
          * Ophthalmology research at Novartis 
      
       * Novartis pipeline 
       * Research collaborations 
       * Collaborations 
      
      Research & development
      
      Discover how Novartis turns breakthrough science into transformative,
      high-value treatments.
       
   
    * ESG 
      
      
      
      
      
       * Access 
         
         
         
         
         
          * Creating sustainable business models 
          * Value-based pricing 
          * Sub-Saharan Africa 
          * Donations 
          * Novartis access principles 
          * Novartis oncology access 
          * Patents and licensing 
         
         
       * Environmental sustainability 
         
         
         
         
         
          * Climate 
          * Waste 
          * Water 
      
       * Ethics, risk and compliance 
         
         
         
         
         
          * Ethical behavior 
          * Compliance 
          * Human rights 
          * Learning and engagement 
          * Risk management 
      
       * Global health 
         
         
         
         
         
          * Pandemic preparedness 
          * Avoidable blindness 
          * Chagas disease 
          * Leprosy 
          * Malaria 
          * Sickle cell disease (SCD) 
          * Novartis Foundation  (link is external)
      
       * Diversity, equity and inclusion 
       * ESG index 
       * Reporting and transparency hub 
         
         
         
         
         
          * Novartis in Society Integrated Report 
          * ESG rating performance 
          * Targets 
          * Patient organization funding 
          * Payments to healthcare professionals 
          * Public policy 
          * A living wage 
          * A safe workplace 
          * Animal research 
      
      Environmental, social and governance
      
      Learn about our commitments to making a positive impact on the world by
      providing access to innovative medicines, protecting the environment, and
      upholding high ethical standards. Explore the Novartis in Society
      Integrated Report.
   
    * Investors 
      
      
      
      
      
       * Event calendar 
       * Financial data 
         
         
         
         
         
          * Novartis annual results 
          * Novartis quarterly results 
          * Novartis SEC filings 
          * Product sales 
          * Fixed-income securities 
          * Expected currency impact 
         
         
       * Share data and analysis 
         
         
         
         
         
          * Share monitor 
          * Dividend information 
          * Share ownership 
          * Share overview 
          * Return on investment calculator 
      
       * Shareholder information 
         
         
         
         
         
          * General Meetings 
          * American Depositary Receipts (ADR) 
          * Share buyback 
          * Frequently asked questions 
      
       * Company overview 
         
         
         
         
         
          * Corporate governance 
      
       * Reporting and transparency hub 
         
         
         
         
         
          * Novartis in Society Integrated Report 
          * Reporting archive 
          * ESG rating performance 
          * Publications order form 
      
       * ESG 
      
      Investors
      
      Updates and resources for investors including financial information,
      disclosures, events, share price, ESG and reporting.
   
    * News 
      
      
      
      
      
       * News archive  
       * Media library  
       * Stories 
       * Subscribe 
      
      News
      
      Information for journalists including media releases, statements, stories,
      multimedia resources and more.
   
    * Careers 
      
      
      
      
      
       * Career search 
       * Our business functions 
         
         
         
         
         
          * Careers in research and development 
          * Careers in operations 
          * Careers in commercial and sales 
          * Careers in global functions 
      
       * Why Novartis 
       * Career hub 
         
         
         
         
         
          * Temporary contracts  (link is external)
      
       * Early careers 
         
         
         
         
         
          * Graduates 
          * Students 
          * US Biomedical Research internship programs 
          * Community exploration and learning lab (CELL) 
      
      Careers
      
      Novartis is hiring! Find open positions, learn more about our strategy and
      culture, and apply today.
   
    * Clinical trials 
    * Partnering 
    * Supplier portal 
    * Report side effects 
    * Contacts 
   
   Home
   
   Working together, we can reimagine medicine to improve and extend people’s
   lives.

Header


REIMAGINING MEDICINE TOGETHER

Working together, we can reimagine medicine to improve and extend people’s
lives.






DISCOVER OUR MEDICINES

Our innovative medicines address society’s greatest disease burdens and restore
possibility for patients.


EXPLORE OUR SCIENCE

Discover how we unravel the mysteries of biology and develop new technologies to
fight disease and change lives.


LEARN ABOUT OUR IMPACT

Creating a medicine is just the beginning of the journey. Discover how we
embrace societal impact as a core business objective.


NOVARTIS FINANCIAL RESULTS – Q1 2024



Novartis announced the company’s financial results for the first quarter of
2024.



Learn more


LATEST NEWS

May 02, 2024

 * Media Update


NOVARTIS ENTERS AGREEMENT TO ACQUIRE MARIANA ONCOLOGY, STRENGTHENING RADIOLIGAND
THERAPY PIPELINE

Apr 24, 2024

 * Media Release


NOVARTIS AND MEDICINES FOR MALARIA VENTURE ANNOUNCE POSITIVE EFFICACY AND SAFETY
DATA FOR A NOVEL TREATMENT FOR BABIES <5 KG WITH MALARIA

Apr 23, 2024

 * Media Release


NOVARTIS RADIOLIGAND THERAPY LUTATHERA® FDA APPROVED AS FIRST MEDICINE
SPECIFICALLY FOR PEDIATRIC PATIENTS WITH GASTROENTEROPANCREATIC NEUROENDOCRINE
TUMORS

All news


THE BURDEN OF IGAN



IgAN nephropathy (IgAN) is a heterogeneous, progressive, rare kidney disease and
is a major cause of chronic kidney disease worldwide. Novartis is working to
slow the progression of this disease and extend a dialysis-free life in
patients.



Learn more


NOVARTIS IN SOCIETY INTEGRATED REPORT 2023



Learn about our business, strategy and performance in 2023, and how we create
sustainable value for stakeholders and society.



View the online summary


WELCOME TO WHERE WE THRIVE TOGETHER

Working together. Learning together. Thriving together. Discover how you can
join us in changing people's lives.

Join us


RESOURCE LINKS

About Novartis
Healthcare Professionals
Patients and Caregivers
Pipeline
Products



NOVARTIS



WORKING TOGETHER

Working together
 * Patients and caregivers
 * Healthcare professionals
 * Researchers
 * Job seekers
 * Journalists
 * Investors

TOPICS

Topics
 * My Cancer. My Words.
 * Access
 * Diversity
 * ESG
 * SpeakUp

EXPLORE

Explore
 * Pipeline
 * Products
 * Clinical trials
 * Partnering
 * Stories

THERAPEUTIC AREAS

Therapeutic areas
 * Cardiovascular, renal and metabolic
 * Immunology
 * Neuroscience
 * Oncology

 * (link is external)
 * (link is external)
 * (link is external)
 * (link is external)
 * (link is external)

Search



FOOTER BOTTOM

Footer Bottom
© 2024 Novartis AG
 * Terms of use
 * Privacy
 * Cookie Settings
 * Contacts
 * Locations
 * Site map
 * Open source
 * Web accessibility

Novartis Site Directory
This site is intended for a global audience




YOUR PRIVACY IS IMPORTANT FOR US.

We use cookies to enhance your experience when visiting our websites:
performance cookies show us how you use this website, functional cookies
remember your preferences and targeting cookies help us to share content
relevant to you. Select “Accept all” for giving your consent to all cookies,
select “Cookie settings” for managing the different cookies or select “Reject
all” for using only strictly necessary cookies. You can change your cookie
settings at any point of time by pressing the cookie settings link on the
website.
Cookie Settings Reject all Accept all



COOKIE PREFERENCE CENTER

When you visit any website, it may store or retrieve information on your browser
by using cookies. The cookies are set to expire when the information is no
longer needed or after a maximum period of 13 months. You can choose to allow or
not to allow some specific types of cookies. Click on the different category
headings below to find out more. Please note that blocking some types of cookies
may impact your experience on the site and the services we are able to offer.
Accept all


MANAGE CONSENT PREFERENCES

STRICTLY NECESSARY COOKIES

Always Active

These cookies are necessary for our websites to function and for measurement. We
do not allow opt-out rights with respect to these cookies.

Cookies Details‎

PERFORMANCE COOKIES

Performance cookies

These cookies allow us to count visits and traffic sources so we can measure and
improve the performance of our site. They help us to know which pages are the
most and least popular and see how visitors move around the site. All
information these cookies collect is aggregated and therefore anonymous. If you
do not allow these cookies we will not know when you have visited our site, and
will not be able to monitor its performance.

Cookies Details‎

FUNCTIONAL COOKIES

Functional cookies

These cookies enable the website to provide enhanced functionality and
personalisation. They may be set by us or by third party providers whose
services we have added to our pages. If you do not allow these cookies then some
or all of these services may not function properly.

Cookies Details‎

TARGETING COOKIES

Targeting cookies

If you provided your email for marketing or disease awareness purposes, you may
need to provide further information to enable us to fully honor your
preferences. Click here to learn more.

Cookies Details‎
Back Button


COOKIE LIST



Search Icon
Filter Icon

Clear
checkbox label label
Apply Cancel
Consent Leg.Interest
checkbox label label
checkbox label label
checkbox label label

Save choices